InvestorsHub Logo
Followers 155
Posts 2608
Boards Moderated 0
Alias Born 01/29/2004

Re: plexrec post# 388578

Sunday, 12/04/2022 3:15:53 PM

Sunday, December 04, 2022 3:15:53 PM

Post# of 458552
Will comment in detail later. Nonetheless, blarcamesine works.

falconer--haven't seen you comment on recent trial news--you still with us? (sure you are)-- MIA ???


I'm here; have been reading and watching.

But my comments right now don't fit with the themes of current postings. The naysayers are certain that the announced trial results were poor, or poorly presented. Consequently, for them, blarcamesine is a failure. Others see (as I do) that at 50mg doses blarcamesine produced very positive therapeutic outcomes; better than any of the existing standard of care (SOC) Alzheimer's drugs.

But to make that claim (as I just did) won't change anyone's perceptions. More data need to be released. Those will be forthcoming, first in the conference call or press release that will soon appear. Second, far more definitive, will be the details in the peer-reviewed journal article that is to appear at some time. Until those two events happen, the messages on this board regarding MIssling, Anavex Life Sciences Corp, and blarcamesine will continue to be in the nature of a few high school girls telling "secrets" about various relationships they know about.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News